Substituting racemic ionizable lipids with stereopure ionizable lipids can increase mRNA delivery.
Ontology highlight
ABSTRACT: Lipid nanoparticles (LNPs) have delivered siRNA and mRNA drugs in humans, underscoring the potential impact of improving the therapeutic window of next-generation LNPs. To increase the LNP therapeutic window, we applied lessons from small-molecule chemistry to ionizable lipid design. Specifically, given that stereochemistry often influences small-molecule safety and pharmacokinetics, we hypothesized that the stereochemistry of lipids within an LNP would influence mRNA delivery. We tested this hypothesis in vivo using 128 novel LNPs that included stereopure derivatives of C12-200, an ionizable lipid that when formulated into LNPs delivers RNA in mice and non-human primates but is not used clinically due to its poor tolerability. We found that a novel C12-200-S LNP delivered up to 2.8-fold a
SUBMITTER: Da Silva Sanchez AJ
PROVIDER: S-EPMC9897220 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA